BRCA1 and neoplasm: Especially, the prognostic impact of the tumor grade deviated highly significantly from the PREDICT model, possibly reflecting underlying differences in the impact of tumor grade on prognosis in BRCA1/2 carriers when compared to the patient populations on which the PREDICT model is based.